Clinical Trial – Pembrolizumab – Advanced Bladder Cancr

The clinical trial is run by National Cancer Institute to apply Pembrolizumab in treating locally advanced bladder cancer.

Trial Name: Pembrolizumab in Treating Patients with Locally Advanced Bladder Cancer

Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 407 locations

Pembrolizumab, trade name KEYTRUDA, is a medicine that may treat certain cancers by working with your immune system.

Please find details on www.cancer.gov

Leave a Reply